Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 1 of the last 1 fiscal years.
-
Tight liquidity NBB
Cash and receivables cover 10 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
Benno Therapeutics from Leuven, company number BE1006661347, closed financial year 2025 with a result of € -790,201 after tax. For that financial year Benno Therapeutics recorded a gross margin of € -194,008 and equity of € -506,759. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 15, 2026.
€ -506,759
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -790,201
Profit after tax over the fiscal year.
€ 35,366
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -790,201.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 81,682
Supplier invoices still open on the last day of the fiscal year.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
What happened to Benno Therapeutics?
What happened at Benno Therapeutics in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 790,201. Source: NBB ↗
- New establishment in Leuven. KBO
- Donna Investco BV became a director. NBB
- Start of the company according to the CBE. KBO
A new publication or filing at Benno Therapeutics? We notify you, reason included.
Follow Benno TherapeuticsDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Benno Therapeutics is Donna Investco BV.
Directors
According to the 2025 annual accounts
Donna Investco BV
Statutair Bestuurder · represented by Erwin Blomsma, Raymond Perrenet
since 2024
Establishments
Establishment units
Physical locations of this company
Ambachtenlaan 1
3001 Leuven
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 1006.661.347
- VAT number
- BE 1006.661.347
- Registered office
- Ambachtenlaan 1, 3001 Leuven
- Names & denominations
- Benno Therapeutics · Benno of BennoTX
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 1 March 2024
- Peppol
- Active · Active since 30 Oct 2025
- Activities · NACE
Speur- en ontwikkelingswerk op biotechnologisch gebied
Diensten in verband met de verzorging van huisdieren, muv veterinaire diensten
Diensten in verband met de verzorging van huisdieren, m.u.v. veterinaire diensten
Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg
Overige gespecialiseerde wetenschappelijke en technische activiteiten